Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Weight Gain After Treatment of Graves’ Disease in Children
source: Clinical Endocrinology
year: 2018
authors: Alonso GT, Rabon S, White PC
summary/abstract:Objective:
The frequency of and risk factors for weight gain in children treated for Graves’ disease have not been described. We evaluated change in BMI-Z score and predictors of weight gain in this population.
Design:
Retrospective review of data from January 2000 to July 2011.
Patients:
Two hundred and twenty two children and adolescents with Graves’ disease (ages 2-18 years) evaluated following radioactive iodine administration (RAI); (n = 101), thyroidectomy (n = 9) and initiation of medical therapy (n = 112).
Measurements:
Changes in body mass index Z score over 12 months (ΔBMI-Z0-12).
Results:
All treatment groups in each gender and race increased BMI-Z (median ΔBMI-Z0-12 was positive). T3 levels following RAI (P = .04) and weight lost at the time of administration (P = .02) in the RAI group and free T4 levels in the medical therapy group (P = .03) were positively correlated with ΔBMI-Z0-12. Race was a significant predictor only in the medical therapy group (P = .01). Age negatively correlated with ΔBMI-Z0-12 in both the RAI (P < .001) and medical therapy groups (P = .003). Gender, maximum TSH in the 12 months after RAI and initial dose of LT4 replacement did not correlate with ΔBMI-Z0-12. The prevalence of overweight and obesity in our cohort was similar to US children.
Conclusions:
Weight gain during treatment for Graves’ disease is common in children, and many children become overweight or obese during treatment. Risk factors include greater degree of hyperthyroidism at presentation and time of RAI and younger age. Weight lost upon presentation may also predict greater weight gain. Control of subsequent hypothyroidism does not appear to affect weight gain.
DOI: 10.1111/cen.13493
read more
myBinderRelated Content
-
Radioactive Iodine Therapy vs. Antithyroid Medications for Graves’ DiseaseGraves disease is the most common cause ...
-
Radioactive Iodine Treatment for HyperthyroidismThe thyroid gland, located at the front ...
-
Treating Graves’ – Different StrokesOnce the diagnosis of hyperthyroidism du...
-
Cancer Mortality Following Treatment for Adult HyperthyroidismContext: High-dose iodine 131 is the tr...
-
Cancer Incidence and Mortality After Radioiodine Treatment for Hyperthyroidism: A Population-Based Cohort StudyBackground: Radioiodine is used increas...
-
Risk Factors of Hepatic Dysfunction in Patients With Graves’ Hyperthyroidism and the Efficacy of 131iodine Tre...Hepatic dysfunction is often observed in...
-
Frequency of Flame Sensor Activation in Public Places After Administration of Radioactive Iodine To Treat GravesR...Objective: Ultraviolet (UV)-perception-...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Facebook
Google